Home
Events that a source expects, grouped by the month, quarter or half-year the source names, with who expected each and when they said so.
Upcoming as of 2026-11-19 , the date this release was built (the newest input commit date), not today's date. An expected date is a statement by the source, not a result, and it can move. Dated events are on the timeline.
8,817 of these dates come from registry records: the start, primary completion or completion that a registry expects of a trial. A program assembled them, and a registry often leaves a date unchanged after it has passed. The calendar file lists the dates of written pages only.
Add to your calendar (calendar.ics)
The calendar file has one all-day event for each upcoming item. Where a source gives only a month, a quarter, a half-year or a year, the event sits on the first day of that period and its title says "expected sometime in" the period.
Upcoming
April 2027 90
2027-04-01
Study completion Combination of Novel Therapies for CKD Comorbid Depression Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04422652
2027-04-01
Study completion Improving Outcome in Subarachnoid Hemorrhage wIth Nadroparine Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT04507178
2027-04-01
2027-04-01
2027-04-01
Study completion ACOART BTK RENEW:A Post Market Clinical Study Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT04885985
2027-04-01
2027-04-01
2027-04-01
2027-04-01
Primary completion Effect of a Healthy Food Voucher on Blood Glucose Control in People With Type 2 Diabetes or Prediabetes Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05776420
2027-04-01
Study completion CTSN Embolic Protection Trial Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06027788
2027-04-01
Primary completion CTSN Embolic Protection Trial Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06027788
2027-04-01
Primary completion Efficacy of MitraCLip Vs. PASCAL for the TrEAtment of MitraL REgurgiTation in an All-comer Population Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06634121
2027-04-01
2027-04-01
2027-04-01
2027-04-01
2027-04-01
2027-04-01
2027-04-01
2027-04-01
2027-04
Study completion Anticoagulation in ICH Survivors for Stroke Prevention and Recovery Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03907046
2027-04
Primary completion Anticoagulation in ICH Survivors for Stroke Prevention and Recovery Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03907046
2027-04
2027-04
2027-04
Primary completion MicroVention, Inc. Flow Re-Direction Endoluminal Device X (FRED™ X™) Post-Approval Study Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT05409989
2027-04
Primary completion ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic Valve Implantation Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05932615
2027-04
2027-04
2027-04
2027-04
2027-04
Primary completion Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07282743
2027-04
2027-04
Primary completion DECODE - Haemodynamic Effects Of Semaglutide and Tirzepatide - a Series of Pilot Studies Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07483801
2027-04
Primary completion Butylphthalide for Brain Edema After Endovascular Treatment Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07528456
2027-04
2027-04
Study completion Mexidol® Safety and Efficacy in Treatment of Hyperacute and Acute Ischemic Stroke Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07575984
2027-04
Primary completion Mexidol® Safety and Efficacy in Treatment of Hyperacute and Acute Ischemic Stroke Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07575984
2027-04
Study completion Using Mobile Stress Management to Reduce Hypertension in African American Men Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07594808
2027-04
Study start Trial of CGM Technology in Persons Living With Prediabetes Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07639593
2027-04
Primary completion The Efficacy and Safety of HRS-4029 in Acute Ischemic Stroke Patients Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07739160
2027-04
Study completion KV-PREDICT Diagnostic Device in Patients With Heart Failure Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07805213
2027-04
Primary completion KV-PREDICT Diagnostic Device in Patients With Heart Failure Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07805213
2027-04
Study completion LDL Cholesterol Reduction Following Ezetimibe Initiation Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07839741
2027-04
Primary completion A Study of HRS-4729 Injection in Participants With Type 2 Diabetes Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07843862
2027-04
2027-04
2027-04-05
2027-04-05
2027-04-08
Study completion Delipid Extracorporeal Lipoprotein Filter From Plasma (DELP) for Acute Hemorrhagic Stroke Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05128513
2027-04-08
Primary completion Delipid Extracorporeal Lipoprotein Filter From Plasma (DELP) for Acute Hemorrhagic Stroke Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05128513
2027-04-08
Primary completion A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07340320
2027-04-10
2027-04-10
Primary completion DUTCH Weight Control in Atrial Fibrillation Study Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06184633
2027-04-14
2027-04-15
Study completion A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07340320
2027-04-16
Study completion Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT03417388
2027-04-16
2027-04-16
2027-04-16
2027-04-16
2027-04-17
Study completion Evaluate the Efficacy and Safety of GZR33 Injection in Patients With Type 2 Diabetes Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07527078
2027-04-19
2027-04-20
2027-04-20
2027-04-21
Study completion Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07175428
2027-04-22
Study completion Cardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07403669
2027-04-25
2027-04-26
Primary completion A Study of DII235 in Adults With Elevated Lipoprotein(a) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07235046
2027-04-27
Primary completion Efficacy and Safety of Maridebart Cafraglutide in Adult Participants in Japan Who Have Obesity Disease Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06987695
2027-04-28
Study completion Efficacy and Safety of XyloCore Peritoneal Dialysis Solution. Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03994471
2027-04-28
Study start Novel Wearable Device for Heart Failure Management Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT05642650
2027-04-28
2027-04-29
Primary completion Personalizing Thromboprophylaxis for Patients With Peripheral Artery Disease Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07613840
2027-04-30
Study completion Neurovascular Transduction During Exercise in Chronic Kidney Disease Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02947750
2027-04-30
Primary completion Neurovascular Transduction During Exercise in Chronic Kidney Disease Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02947750
2027-04-30
Primary completion Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT04924322
2027-04-30
2027-04-30
Primary completion Intracoronary Stenting and Additional Results Achieved by ShockWAVE Coronary Lithotripsy Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06369142
2027-04-30
Primary completion Esprit BTK Post-Approval Study Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT06656364
2027-04-30
Primary completion Study on the Aortic Arch Single Branch Stent Graft System Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT06915545
2027-04-30
Study completion A Study of BGM0504 in Participants With Type 2 Diabetes in Indonesia Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07064486
2027-04-30
Primary completion A Study of BGM0504 in Participants With Type 2 Diabetes in Indonesia Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07064486
2027-04-30
2027-04-30
2027-04-30
Study completion Left Bundle Branch Area Pacing (LBBAP) PMCF Study Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07217392
2027-04-30
Primary completion Left Bundle Branch Area Pacing (LBBAP) PMCF Study Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07217392
2027-04-30
2027-04-30
Primary completion Covered vs Bare Metal Stents for Atherosclerotic Renal Artery Stenosis Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07566065
2027-04-30
Primary completion A Study of SYH2070 Injection in Participants With Mixed Hyperlipidemia Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07695597
2027-04-30
Overdue
The expected date has passed and no published record says the event happened. This does not mean it failed or was delayed: the atlas may not have checked the source since. Oldest first.
2017-12
Primary completion Using 3D Imaging to Optimize Bifurcation Stenting Registry record
Expected 2017-12; that period ended on 2017-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02972489
2017-12
Primary completion The New Pharmaceutical Composition Containing Botulinum Toxin to Treat Atrial Fibrillation Registry record
Expected 2017-12; that period ended on 2017-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02982434
2017-12
Primary completion Epicardial Fat Pads Ablation During Coronary Surgery Registry record
Expected 2017-12; that period ended on 2017-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02984371
2017-12
Primary completion Effect of Acarbose and Vildagliptin on Visceral Fat Distribution in Newly Diagnosed Type 2 Diabetes Patients Registry record
Expected 2017-12; that period ended on 2017-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02999841
2017-12
Primary completion Chewing Ticagrelor Versus Prasugrel in ST-elevation Myocardial Infarction - A Platelet Reactivity Study Registry record
Expected 2017-12; that period ended on 2017-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03016611
2017-12-31
Primary completion Efficacy and Safety of Salvianolate Injection in Elderly Patients With Unstable Angina Pectoris Registry record
Expected 2017-12-31; that period ended on 2017-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT03037047
2017-12
Primary completion Study on Vulnerable Plaque of Carotid Artery With Chinese Herbal and Insects Medicine Registry record
Expected 2017-12; that period ended on 2017-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03072225
2017-12-31
Primary completion Low Dose Statins, Ezetimibe and Nutraceuticals Registry record
Expected 2017-12-31; that period ended on 2017-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03277079
2018-01-01
Study start Effect of Vasopressin, Steroid, and Epinephrine Treatment in Patients With Out-of-hospital Cardiac Arrest Registry record
Expected 2018-01-01; that period ended on 2018-01-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03317197
2018-01-30
Primary completion Thromboprophylaxis in Patients Undergoing Orthopedic Surgeries; Comparison Between Rivaroxaban and Enoxaparin Registry record
Expected 2018-01-30; that period ended on 2018-01-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT03299296
2018-01
Study completion Exenatide for Myocardial Protection During Reperfusion Study Registry record
Expected 2018-01; that period ended on 2018-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01938235
2018-01
Study completion Right Ventricular Dysfunction in Tetralogy of Fallot: Inhibition of the Renin-angiotensin-aldosterone System Registry record
Expected 2018-01; that period ended on 2018-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02010905
2018-01
Primary completion Right Ventricular Dysfunction in Tetralogy of Fallot: Inhibition of the Renin-angiotensin-aldosterone System Registry record
Expected 2018-01; that period ended on 2018-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02010905
2018-01
Primary completion Sedation Depth in Neurocritical Care Registry record
Expected 2018-01; that period ended on 2018-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02317497
2018-01
Primary completion Ablation of Paroxysmal Atrial Fibrillation Using the Appropriate Contact Force in a Chinese Population Registry record
Expected 2018-01; that period ended on 2018-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02493075
2018-01
Study completion Evaluate the Effect of Saxagliptin on Gut Microbiota in Patients With Newly Diagnosed Type 2 Diabetes Registry record
Expected 2018-01; that period ended on 2018-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02583438
2018-01
Primary completion The Efficacy and Safety Study of Dabigatran and Warfarin to Non-valvular Atrial Fibrillation Patients Registry record
Expected 2018-01; that period ended on 2018-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02646267
2018-01
Primary completion Temporary Pacemaker in Transcatheter Aortic Valve Implantation Patients Registry record
Expected 2018-01; that period ended on 2018-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02768064
2018-01
Study completion Ticagrelor Versus Clopidogrel in Myocardial Salvage in Patients With STEMI Undergoing Primary PCI Registry record
Expected 2018-01; that period ended on 2018-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT02792712
2018-01
Primary completion Ticagrelor Versus Clopidogrel in Myocardial Salvage in Patients With STEMI Undergoing Primary PCI Registry record
Expected 2018-01; that period ended on 2018-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT02792712
2018-01
Primary completion Determination of Left Ventricular Ejection Fraction Using Cardiac Angioscintigraphy Registry record
Expected 2018-01; that period ended on 2018-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT02869308
2018-01
Study completion Effect of Acarbose and Vildagliptin on Visceral Fat Distribution in Newly Diagnosed Type 2 Diabetes Patients Registry record
Expected 2018-01; that period ended on 2018-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02999841
2018-02-01
Study start The Safety and Effectiveness of Transcatheter Aortic Valve Raplacemet in Intermediate Risk Patients With Bicuspid Aortic Stenosis Registry record
Expected 2018-02-01; that period ended on 2018-02-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03163329
2018-02-15
Study start Empagliflozin Versus Placebo on the Rate of Arrhythmic Events in Heart Failure Patients Registry record
Expected 2018-02-15; that period ended on 2018-02-15.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03271879
2018-02
Primary completion Comparing the Effects of Spironolactone With Chlortalidone on LV Mass in Patients With CKD Registry record
Expected 2018-02; that period ended on 2018-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02502981
2018-02
Study completion NP202 for Treatment of Post -STEMI Left Ventricular Systolic Dysfunction Registry record
Expected 2018-02; that period ended on 2018-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02557217
2018-02
Study completion The Fluid Therapy Strategy of the Non-dehydrated Patients With Acute Ischemic Stroke. Registry record
Expected 2018-02; that period ended on 2018-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02668848
2018-02
Study completion Randomized Controlled Trial of Renal Denervation for Resistant Hypertension Registry record
Expected 2018-02; that period ended on 2018-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02900729
2018-02
Primary completion Safety and Clinical Performance of a Sirolimus-eluting Absorbable Metal Scaffold Registry record
Expected 2018-02; that period ended on 2018-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02916485
2018-02
Study completion The New Pharmaceutical Composition Containing Botulinum Toxin to Treat Atrial Fibrillation Registry record
Expected 2018-02; that period ended on 2018-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02982434
2018-02
Study completion Epicardial Fat Pads Ablation During Coronary Surgery Registry record
Expected 2018-02; that period ended on 2018-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02984371
2018-03-06
Study start Transplantation Efficacy of Autologous Bone Marrow Mesenchymal Stem Cells With Intensive Atorvastatin in AMI Patients Registry record
Expected 2018-03-06; that period ended on 2018-03-06.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03047772
2018-03-15
Study start Prevention of Acute Kidney Injury by N-Acetylcystein in Patients Undergone Cardiac Valve Replacement Registry record
Expected 2018-03-15; that period ended on 2018-03-15.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03440268
2018-03-26
Study start CPAP for OSA on Myocardial Salvage After pPCI for STEMI Patients Registry record
Expected 2018-03-26; that period ended on 2018-03-26.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03444857
2018-03-30
Study completion Thromboprophylaxis in Patients Undergoing Orthopedic Surgeries; Comparison Between Rivaroxaban and Enoxaparin Registry record
Expected 2018-03-30; that period ended on 2018-03-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT03299296
2018-03-30
Study start Improvement of Cardiac Function in Patients With Ischemic Cardiomyopathy by Extracorporeal Shock Wave Therapy: a Multicenter Clinical Study Registry record
Expected 2018-03-30; that period ended on 2018-03-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03398096
2018-03
Study completion Sham Controlled Study of Renal Denervation for Subjects With Uncontrolled Hypertension Registry record
Expected 2018-03; that period ended on 2018-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02029885
2018-03
Study completion Pyridorin in Diabetic Nephropathy Registry record
Expected 2018-03; that period ended on 2018-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02156843
2018-03
Study completion Effects of Limb Ischemic Postconditioning in Young sICAS Registry record
Expected 2018-03; that period ended on 2018-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02323425
2018-03
Primary completion Effects of Limb Ischemic Postconditioning in Young sICAS Registry record
Expected 2018-03; that period ended on 2018-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02323425
2018-03
Study completion The Impact of Rosuvastatin on the Density Score of Coronary Artery Calcification in CAD Patients With Diabetes Mellitus Registry record
Expected 2018-03; that period ended on 2018-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02418884
2018-03
Primary completion The Impact of Rosuvastatin on the Density Score of Coronary Artery Calcification in CAD Patients With Diabetes Mellitus Registry record
Expected 2018-03; that period ended on 2018-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02418884
2018-03
Primary completion Bioresorbable Polymer ORSIRO Versus Durable Polymer RESOLUTE ONYX Stents Registry record
Expected 2018-03; that period ended on 2018-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02508714
2018-03
Study completion Botulinum Toxin Injection Into Epicardial Fat Pads to Prevent Atrial Fibrillation in Patients Undergoing Cardiac Surgery Registry record
Expected 2018-03; that period ended on 2018-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02617069
2018-03
Primary completion Dual AntiPlatelet Therapies for Prevention of Periinterventional Embolic Events in TAVI Registry record
Expected 2018-03; that period ended on 2018-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03001960
2018-03-31
Study completion S-amlodipine+Chlorthalidone vs S-amlodipine+Telmisartan in Hypertension Registry record
Expected 2018-03-31; that period ended on 2018-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03226340
2018-03-31
Primary completion S-amlodipine+Chlorthalidone vs S-amlodipine+Telmisartan in Hypertension Registry record
Expected 2018-03-31; that period ended on 2018-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03226340
2018-03
Primary completion Pharmacogenomics of Hypertension Personalized Medicine (PGX-HT) Registry record
Expected 2018-03; that period ended on 2018-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03249285
2018-03-31
Study completion Low Dose Statins, Ezetimibe and Nutraceuticals Registry record
Expected 2018-03-31; that period ended on 2018-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03277079
2018-04-01
Study completion Basal-bolus Insulin Therapy Versus Standard Therapy for the Inpatient Management of Type 2 Diabetes: the IDA2 Study Registry record
Expected 2018-04-01; that period ended on 2018-04-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03244241
2018-04-01
Primary completion Basal-bolus Insulin Therapy Versus Standard Therapy for the Inpatient Management of Type 2 Diabetes: the IDA2 Study Registry record
Expected 2018-04-01; that period ended on 2018-04-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03244241
2018-04-01
Study start Management of Ischemic Heart Disease With Angiwell-XR (Ranolazine) Registry record
Expected 2018-04-01; that period ended on 2018-04-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT03486561
2018-04
Study completion Exercise For Sub-acute Stroke Patients in Jamaica Registry record
Expected 2018-04; that period ended on 2018-04-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01392391
2018-04
Primary completion Exercise For Sub-acute Stroke Patients in Jamaica Registry record
Expected 2018-04; that period ended on 2018-04-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01392391
2018-04
Study completion Pressure Wire Guided Cardiac Resynchronisation Therapy Registry record
Expected 2018-04; that period ended on 2018-04-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01464502
2018-04
Primary completion Pressure Wire Guided Cardiac Resynchronisation Therapy Registry record
Expected 2018-04; that period ended on 2018-04-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01464502
2018-04
Study completion Perceval S Aortic Heart Valve Study- North America Registry record
Expected 2018-04; that period ended on 2018-04-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01810679
2018-04
Primary completion Prospects for the Prevention of Pregnancy-induced Hypertension and Preeclampsia Trial Registry record
Expected 2018-04; that period ended on 2018-04-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02007837
2018-04
Primary completion Performance of Bioresorbable Scaffold in Primary Percutaneous Intervention of ST Elevation Myocardial Infarct Registry record
Expected 2018-04; that period ended on 2018-04-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02067091
2018-04
Primary completion Diuretic Versus Placebo in Pulmonary Embolism Registry record
Expected 2018-04; that period ended on 2018-04-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT02268903
2018-04
Study completion Follow-up Safety Trial in Children With Chronic Heart Failure Therapy Receiving Orodispersible Minitablets of Enalapril Registry record
Expected 2018-04; that period ended on 2018-04-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02654678
2018-04
Primary completion Follow-up Safety Trial in Children With Chronic Heart Failure Therapy Receiving Orodispersible Minitablets of Enalapril Registry record
Expected 2018-04; that period ended on 2018-04-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02654678
2018-04-30
Study completion Metformin Pharmacokinetics in Patients With Chronic and Acute Heart Failure Registry record
Expected 2018-04-30; that period ended on 2018-04-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02797340
2018-04-30
Primary completion Metformin Pharmacokinetics in Patients With Chronic and Acute Heart Failure Registry record
Expected 2018-04-30; that period ended on 2018-04-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02797340
2018-04
2018-04
2018-04
Study completion Dual AntiPlatelet Therapies for Prevention of Periinterventional Embolic Events in TAVI Registry record
Expected 2018-04; that period ended on 2018-04-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03001960
2018-05-14
Study start Evaluating the Effect of Spironolactone on Hypertrophic Cardiomyopathy Registry record
Expected 2018-05-14; that period ended on 2018-05-14.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT02948998
2018-05
Study completion Diuretic Versus Placebo in Pulmonary Embolism Registry record
Expected 2018-05; that period ended on 2018-05-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT02268903
2018-05
Study completion Bipolar Radiofrequency Ablation Plus Argon Beam Coagulator Ablation for Atrial Fibrillation Registry record
Expected 2018-05; that period ended on 2018-05-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02424110
2018-05
Primary completion Bipolar Radiofrequency Ablation Plus Argon Beam Coagulator Ablation for Atrial Fibrillation Registry record
Expected 2018-05; that period ended on 2018-05-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02424110
2018-05
Study completion Comparing the Effects of Spironolactone With Chlortalidone on LV Mass in Patients With CKD Registry record
Expected 2018-05; that period ended on 2018-05-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02502981
2018-05
Primary completion Intensive Versus Conventional Digoxin Use in Patients With Heart Failure Registry record
Expected 2018-05; that period ended on 2018-05-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02797145
2018-05
Study completion Determination of Left Ventricular Ejection Fraction Using Cardiac Angioscintigraphy Registry record
Expected 2018-05; that period ended on 2018-05-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT02869308
2018-05
Study completion Assessing Neurodevelopment in Congenital Heart Disease. Registry record
Expected 2018-05; that period ended on 2018-05-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02996630
2018-05
Primary completion Effect of Preoperative Aspirin in Patients Undergoing Off-pump Coronary Artery Bypass Grafting Registry record
Expected 2018-05; that period ended on 2018-05-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03049085
2018-06-01
Study start Tecarfarin Anti-Coagulation Trial (TACT) Registry record
Expected 2018-06-01; that period ended on 2018-06-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02522221
2018-06-06
Study start Intensive Insulin for Severe/Moderate Hypertriglyceridemia Pancreatitis. Registry record
Expected 2018-06-06; that period ended on 2018-06-06.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT03501680
2018-06-08
Study start Effect of External Counter Pulsation on Coronary Artery Disease Registry record
Expected 2018-06-08; that period ended on 2018-06-08.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03075124
2018-06-10
Study start Effect of External Counter Pulsation on Ischemic Stroke Registry record
Expected 2018-06-10; that period ended on 2018-06-10.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03075137
2018-06-15
Study start Neuroprotectant for Hypertensive Intracerebral Hemorrhage Registry record
Expected 2018-06-15; that period ended on 2018-06-15.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT03546283
2018-06
Study completion Medical ANtiarrhythmic Treatment or Radiofrequency Ablation in Ischemic Ventricular Tachyarrhythmias Registry record
Expected 2018-06; that period ended on 2018-06-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02303639
2018-06
Study completion Dose-effect Relationship of Rt-PA on ICH Evacuation Registry record
Expected 2018-06; that period ended on 2018-06-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT02472574
2018-06
Primary completion Dose-effect Relationship of Rt-PA on ICH Evacuation Registry record
Expected 2018-06; that period ended on 2018-06-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT02472574
2018-06
Study completion Ablation of Paroxysmal Atrial Fibrillation Using the Appropriate Contact Force in a Chinese Population Registry record
Expected 2018-06; that period ended on 2018-06-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02493075
2018-06
Primary completion Ulinastatin Injection in in Pediatric Patients Undergoing Open Heart Surgery Registry record
Expected 2018-06; that period ended on 2018-06-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02527811
2018-06
Primary completion A Randomized Controlled Trial of Sertraline in Paroxysmal Arterial Hypertension Registry record
Expected 2018-06; that period ended on 2018-06-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02641652
2018-06
Study completion Intensive Versus Conventional Digoxin Use in Patients With Heart Failure Registry record
Expected 2018-06; that period ended on 2018-06-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02797145
2018-06
Primary completion Renal Denervation by Iberis MultiElectrode Renal Denervation System in Patients With Primary Hypertension Registry record
Expected 2018-06; that period ended on 2018-06-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02901704
2018-06
Primary completion Study of Safety and Efficacy of a Left Atrial Appendage Occulder Registry record
Expected 2018-06; that period ended on 2018-06-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02937025
2018-06
2018-06
2018-06
Study completion To Evaluate Safety and Efficacy of CGBIO Stent Compared to Biomatrix Flex Stent Registry record
Expected 2018-06; that period ended on 2018-06-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03089450
2018-06-30
Primary completion Improvement of Cardiac Function in Patients With Ischemic Cardiomyopathy by Extracorporeal Shock Wave Therapy: a Multicenter Clinical Study Registry record
Expected 2018-06-30; that period ended on 2018-06-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03398096
2018-07-10
Primary completion the Efficacy and Safety of Indobufen and Low-dose Aspirin in Different Regimens of Antiplatelet Therapy Registry record
Expected 2018-07-10; that period ended on 2018-07-10.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03230851
2018-07
Primary completion Insulin Glargine Versus Regular Insulin Based Regimens in Glycemic Control After Acute Stroke Registry record
Expected 2018-07; that period ended on 2018-07-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02607943
2018-07
Primary completion Adenosine as an Adjunct to Blood Cardioplegia Registry record
Expected 2018-07; that period ended on 2018-07-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT02681913
2018-07
Primary completion Rule Out Transcatheter Aortic Valve Thrombosis With Post Implantation Computed Tomography (RETORIC) Registry record
Expected 2018-07; that period ended on 2018-07-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02826200
2018-07
Primary completion Ad-HGF Treatment for Myocardial Infarction Registry record
Expected 2018-07; that period ended on 2018-07-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02844283
2018-07-31
Primary completion A Randomized Control Trial of Vitamin D Prophylaxis in the Prevention of Hypertensive Disorders of Pregnancy Registry record
Expected 2018-07-31; that period ended on 2018-07-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02920593